Similar Articles
921 Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
922 Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
923 Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
924 Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis
925 Development of a prognostic scoring system for resectable hepatocellular carcinoma
926 Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma
927 Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma
928 Aberrant regulation of Wnt signaling in hepatocellular carcinoma
929 Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
930 Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA